You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
四環醫藥(00460.HK)四款醫用皮膚護理敷料敷貼類產品獲醫療器械註冊證
格隆匯 03-02 07:19

格隆匯3月2日丨四環醫藥(00460.HK)發佈公吿,集團旗下渼顏空間生物科技(吉林)有限公司自主研發四項醫用皮膚護理敷料敷貼類產品,包括醫用皮膚護理敷料、醫用皮膚護理敷貼、醫用濕性修復敷料及醫用濕性修復敷貼,已獲得中國國家藥品監督管理局頒發的II類醫療器械註冊證。

公吿表示,本次獲批的四款產品遵循醫美術後創口修復的“濕性癒合理論”,能有效幫助皮膚傷口在濕潤低氧環境下,使膠原纖維和上皮細胞快速生成,同時刺激細胞因子分泌,減少污染,加速傷口癒合。醫用皮膚護理敷料敷貼類產品憑藉其安全性高,刺激性弱,過敏率低,使用方便等特點,在醫美行業的應用受到了求美者及醫美專業醫師的廣泛歡迎,成為在非手術醫美項目如激光手術、果酸煥膚、熱瑪吉、水光針、微針等治療後,常用的術後皮膚護理產品,以達到補水修護、舒緩皮膚等醫用皮膚護理功效。且該等產品銷售渠道廣泛,不僅可用於美容院、超市、店鋪等,還可以在藥店、醫院進行銷售。

此次醫用皮膚護理敷料、醫用皮膚護理敷貼、醫用濕性修復敷料及醫用濕性修復貼四款產品獲批,是渼顏空間繼童顏水凝嘉樂妍®、醫用皮膚修復凝膠、醫用疤痕修復類產品獲批後又新增的四款自研醫用皮膚護理類產品,可與集團代理的黃金微針等光電類產品形成有效的產品組合,實現1+1>2的緊膚及舒緩的雙重效果。該四款產品的獲批不僅再次證明了渼顏空間強大的研發實力和快速註冊的能力,同時進一步豐富和擴大了集團醫美平台渼顏空間的皮膚護理類的產品組合。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account